Ouabain is an endogenous substance occurring in the plasma in the nano
molar range, that has been proposed to increase vascular resistance an
d induce hypertension. This substance acts on the alpha-subunit of Na,K+-ATPase inhibiting the Na+-pump activity. In the vascular smooth mu
scle this effect leads to intracellular Na+ accumulation that reduces
the activity of the Na+/Ca2+ exchanger and to an increased vascular to
ne. It was also suggested that circulating ouabain, even in the nanomo
lar range, sensitizes the vascular smooth muscle to vasopressor substa
nces. We tested the latter hypothesis by studying the effects of ouaba
in in the micromolar and nanomolar range on phenylephrine (PE)-evoked
presser responses. The experiments were performed in normotensive and
hypertensive rats in vivo, under anesthesia, and in perfused rat tail
vascular beds. The results showed that ouabain pretreatment increased
the vasopressor responses to PE in vitro and in vivo. This sensitizati
on after ouabain treatment was also observed in hypertensive animals w
hich presented an enhanced vasopressor response to PE in comparison to
normotensive animals. It is suggested that ouabain at nanomolar conce
ntrations can sensitize vascular smooth muscle to vasopressor stimuli
possibly contributing to increased tone in hypertension.